Spot Trading’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-800
Closed -$89.1K 3549
2016
Q3
$84K Sell
800
-20,341
-96% -$2.2M ﹤0.01% 2473
2016
Q2
$2.08M Sell
21,141
-78,437
-79% -$8.11M 0.04% 666
2016
Q1
$9.97M Buy
99,578
+31,691
+47% +$3.26M 0.18% 124
2015
Q4
$8.13M Sell
67,887
-21,976
-24% -$2.54M 0.08% 310
2015
Q3
$9.72M Buy
89,863
+57,827
+181% +$7.18M 0.09% 257
2015
Q2
$3.71M Buy
32,036
+9,427
+42% +$1.08M 0.03% 730
2015
Q1
$2.61M Buy
22,609
+537
+2% +$64.2K 0.03% 933
2014
Q4
$2.47M Buy
22,072
+15,975
+262% +$1.68M 0.02% 1239
2014
Q3
$578K Buy
6,097
+4,229
+226% +$382K ﹤0.01% 2456
2014
Q2
$160K Sell
1,868
-31,072
-94% -$2.36M ﹤0.01% 3472
2014
Q1
$2.3M Sell
32,940
-15,104
-31% -$1.2M 0.01% 1387
2013
Q4
$4.06M Sell
48,044
-84,920
-64% -$6.72M 0.02% 1023
2013
Q3
$10.2M Buy
132,964
+48,642
+58% +$3.41M 0.06% 356
2013
Q2
$4.93M Buy
+84,322
New +$5.07M 0.03% 725

Other funds holding CELG

Spot Trading's CELG Position: Q4 2016 in Review

Spot Trading sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 800 shares — an estimated $89.1K sold.

Spot Trading first reported a position in CELG in Q2 2013 and held it in 14 quarters. The position peaked at $10.2M in Q3 2013. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Spot Trading reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 800 Celgene Corp shares in Q4 2016, an estimated $89.1K.
  • Spot Trading first reported a position in Celgene Corp in Q2 2013 and held it in 14 quarters.
  • Spot Trading's Celgene Corp position peaked at $10.2M in Q3 2013.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.